Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 1.00 |
| ▸ | CNR1 | P21554 | 5/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.76 |
| ▸ | MAPT | P10636 | 3/20 | 0.76 |
| ▸ | THRB | P10828 | 1/20 | 0.76 |
| ▸ | FAAH | O00519 | 3/20 | 0.66 |
| ▸ | CNR2 | P34972 | 3/20 | 0.63 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | PPARG | P37231 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.58 |
| ▸ | FABP4 | P15090 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3663195 | 1.00 | MGLL (1.00) | MGLLCNR1ALDH1A1MAPTTHRB | |
| SCHEMBL29513053 | 0.97 | MGLL (0.94) | MGLLCNR1ALDH1A1MAPTTHRB | |
| SCHEMBL17685834 | 0.95 | MGLL (0.91) | MGLLCNR1ALDH1A1MAPTTHRB | |
| SCHEMBL3280959 | 0.95 | MGLL (0.91) | MGLLCNR1ALDH1A1MAPTTHRB | |
| Ethylene SCHEMBL9014239 | 0.93 | MGLL (0.86) | MGLLCNR1ALDH1A1MAPTTHRB | |
| SCHEMBL3660643 | 0.92 | MGLL (0.86) | MGLLCNR1ALDH1A1MAPTTHRB | |
| SCHEMBL3660645 | 0.92 | MGLL (0.86) | MGLLCNR1ALDH1A1MAPTTHRB | |
| SCHEMBL29454640 | 0.92 | MGLL (0.85) | MGLLCNR1ALDH1A1MAPTTHRB | |
| SCHEMBL3656524 | 0.90 | MGLL (0.82) | MGLLCNR1ALDH1A1MAPTTHRB | |
| SCHEMBL3660029 | 0.90 | MGLL (0.82) | MGLLCNR1ALDH1A1MAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8425784-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2013-04-23 | — | — | US | claimed |
| EP-3978269-B1 | TIRE | SUMITOMO RUBBER IND (JP) | 2026-03-11 | — | — | EP | disclosed |
| EP-3848209-B1 | TIRE AND METHOD OF EVALUATING TIRE GRIP PERFORMANCE | SUMITOMO RUBBER IND (JP) | 2023-11-01 | — | — | EP | disclosed |
| US-20220251347-A1 | TIRE | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2022-08-11 | — | — | US | disclosed |
| EP-3978269-A1 | TIRE | Sumitomo Rubber Industries, Ltd. (JP) | 2022-04-06 | — | — | EP | disclosed |
| EP-2209547-B1 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | UNIV KANSAS (US) | 2018-06-20 | — | — | EP | disclosed |
| US-8801939-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2014-08-12 | — | — | US | disclosed |
| US-20130240781-A1 | Ozonolysis Reactions in Liquid CO2 and CO2-Expanded Solvents | ARCHER DANIELS MIDLAND COMPANY (US) | 2013-09-19 | — | — | US | disclosed |
| US-8425784-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2013-04-23 | — | — | US | disclosed |
| US-8420602-B2 | May be coupled with endorphin, enkephalin, dynorphin or endomorphin; for traversing blood brain barrier | MILLER LANDON C G (US) | 2013-04-16 | — | — | US | disclosed |
| EP-2209547-A2 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | University Of Kansas (US) | 2010-07-28 | — | — | EP | disclosed |
| US-20100113595-A1 | Treatment of neurodegenerative conditions | BTG INTERNATIONAL LIMITED (GB) | 2010-05-06 | — | — | US | disclosed |
| WO-2009061806-A2 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | UNIVERSITY OF KANSAS (US) | 2009-05-14 | — | — | WO | disclosed |
| US-20090118498-A1 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | ARCHER DANIELS MIDLAND COMPANY | 2009-05-07 | — | — | US | disclosed |
| US-4364743-A | ESTER AND MIDDLE OIL | ERNER WILLIAM E | 1982-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113595-A1 | Treatment of neurodegenerative conditions | DGAT2, ALOX12, DGKG | MGLL 21/4885CNR1 660/4885ALDH1A1 1038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.